证券代码：600200 证券简称：*ST苏吴 公告编号：临2025-135 江苏吴中医药发展股份有限公司 股票交易异常波动的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要风险提示： 江苏吴中医药发展股份有限公司（以下简称"公司"）股票于 2025 年 11 月 19 日、2025 年 11 月 20 日、2025 年 11 月 21 日连续三个交易日内收盘价 格涨幅偏离值累计超过 12%，根据《上海证券交易所交易规则》的有关规定，属 于股票交易异常波动的情形。 江苏吴中医药发展股份有限公司(以下简称"公司")因涉嫌信息披露违 法违规，被中国证券监督管理委员会（以下简称"中国证监会"）立案调查。2025 年 7 月 13 日，公司收到中国证监会下发的《行政处罚事先告知书》（处罚字〔2025〕 58 号）。认定公司虚增营业收入、营业成本和利润，2020 年至 2023 年年度报告 存在虚假记载，触及重大违法强制退市情形。公司股票已于 2025 年 7 月 14 日起 被叠加实施重大违法类强制退市风险警示。 如根据正式的 ...

Core Viewpoint - Aimeike, once a leading player in the medical beauty industry, is facing significant challenges with declining performance and ongoing disputes over product agency rights, prompting a recent board reshuffle to address these issues [1][2][6]. Company Overview - Aimeike's actual controller, Jian Jun, was re-elected as chairman, while the management team remains stable, with Li Dongmei being promoted to a key role amid the company's current challenges [1][2]. - The company has seen a drastic decline in stock price and market capitalization, dropping from a peak of over 150 billion yuan to around 45 billion yuan [2][6]. Financial Performance - In the first half of 2025, Aimeike reported a revenue of 5.66 billion yuan and a net profit of 3.04 billion yuan, marking declines of 21.27% and 34.61% year-on-year, respectively [2][6]. - The company experienced its first negative growth in 2025, with revenue and net profit both declining over 20% [6][7]. Product Development and Market Position - Aimeike's growth has been closely tied to its innovative product development, with key products like "HiTi" and "Luhua Tianzi" driving significant revenue [3][5]. - The company has expanded its product matrix, with "HiTi" achieving a revenue share increase from 15.34% in 2017 to 43.5% in 2019 [4]. Competitive Landscape - The medical beauty industry is undergoing rapid changes, with increased competition leading to a dilution of Aimeike's product advantages, particularly for "HiTi" and "Luhua Tianzi" [7][8]. - New entrants in the market have intensified competition, with the number of approved "童颜针" products increasing to seven, further squeezing Aimeike's growth potential [8][9]. Strategic Initiatives - Aimeike is diversifying its product offerings, including the launch of new products like "Kela" and expanding into biopharmaceuticals and chemical drugs [9][10]. - The company has also pursued acquisitions, such as the purchase of a majority stake in REGEN, to enhance its product portfolio and market competitiveness [10][11]. Legal and Regulatory Challenges - Aimeike is embroiled in a significant dispute over the agency rights for its product "AestheFill," which could impact its market performance and brand partnerships [11][12]. - The ongoing arbitration with Jiangsu Wuzhong over the exclusive distribution rights of "AestheFill" highlights the complexities of brand ownership and distribution in the medical beauty sector [12][15].

证券代码：600200 证券简称：*ST 苏吴 公告编号：临 2025-134 本公司董事会及董事会全体成员保证公告内容不存在虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实、准确和完整承担法律责任。 重要风险提示： 江苏吴中医药发展股份有限公司(以下简称"公司")因涉嫌信息披露违 法违规，被中国证券监督管理委员会（以下简称"中国证监会"）立案 调查。2025 年 7 月 13 日，公司收到中国证监会下发的《行政处罚事先 告知书》（处罚字〔2025〕58 号）。认定公司虚增营业收入、营业成本 和利润，2020 年至 2023 年年度报告存在虚假记载，触及重大违法强制 退市情形。公司股票已于 2025 年 7 月 14 日起被叠加实施重大违法类强 制退市风险警示。 如根据正式的处罚决定书结论，公司触及重大违法强制退市情形，公司 股票将被终止上市。根据《上海证券交易所股票上市规则》，如公司后 续收到行政处罚决定书，认定公司触及重大违法类强制退市情形，公司 将申请停牌，并及时披露有关内容；复牌后，公司股票进入退市整理期。 退市整理期届满后 5 个交易日内，上海证券交易所对上市公司股票予以 摘牌，公司股票终止上市 ...

Core Points - The average stock price of A-shares is 13.67 yuan, with 22 stocks priced below 2 yuan, the lowest being *ST Yuan Cheng at 0.58 yuan [1] - Among the low-priced stocks, 8 are ST stocks, accounting for 36.36% of the total [1] - The Shanghai Composite Index closed at 3931.05 points as of November 20 [1] Low-Priced Stocks Summary - The lowest priced stock is *ST Yuan Cheng at 0.58 yuan, with a market sector of construction decoration [1] - *ST Su Wu and *ST Jin Ke follow with closing prices of 1.07 yuan and 1.48 yuan, respectively, in the pharmaceutical and real estate sectors [1] - Among the low-priced stocks, 6 increased in price today, with *ST Su Wu leading at a 4.90% increase [1] Market Performance - 10 low-priced stocks experienced declines, with ST Yi Gou and *ST Hui Feng showing the largest drops at 2.21% and 2.17%, respectively [1] - The trading volume for *ST Su Wu was notable with a turnover rate of 10.86% [1] - The price-to-book ratio for *ST Yuan Cheng is 0.27, indicating a low valuation compared to its book value [1]

重要风险提示： 证券代码：600200 证券简称：*ST苏吴 公告编号：临2025-133 江苏吴中医药发展股份有限公司 关于股票交易暨退市风险提示公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 三、大额资金占用尚未解决风险 公司股票价格今日盘中涨幅较大，可能存在市场情绪过热及非理性炒作 迹象，积累了较大交易风险，存在随时快速下跌的风险。公司存在重大违法强制 退市、财务类退市、面值退市等多重退市风险。同时存在控股股东大额资金占用 尚未解决、控股股东所持股份被全部冻结、医美产品独家代理权仲裁结果存在不 确定性等经营风险。敬请广大投资者理性投资、审慎决策，切勿盲目跟风炒作， 避免因公司股价波动造成投资损失。 2025 年 7 月 13 日，公司收到中国证券监督管理委员会（以下简称"中 国证监会"）下发的《行政处罚事先告知书》（处罚字〔2025〕58 号），认定 公司虚增营业收入、营业成本和利润，2020 年至 2023 年年度报告存在虚假记载， 触及重大违法强制退市情形。如公司后续收到行政处罚决定书，显示公司触及重 大违法类 ...

Core Points - The average stock price of A-shares is 13.75 yuan, with 23 stocks priced below 2 yuan, the lowest being *ST Yuan Cheng at 0.58 yuan [1] - As of November 19, the Shanghai Composite Index closed at 3946.74 points, indicating a relatively low proportion of both high-priced and low-priced stocks in the A-share market [1] Low-Priced Stocks Summary - Among the low-priced stocks, 8 are ST stocks, accounting for 34.78% of those priced below 2 yuan [1] - The stocks that increased in price today include *ST Su Wu, ST Lingnan, and *ST Hui Feng, with gains of 5.15%, 4.30%, and 1.66% respectively [1] - The majority of low-priced stocks, 19 in total, experienced declines, with Rongsheng Development, Yatai Group, and Beichen Industry showing the largest drops of 5.46%, 3.88%, and 3.54% respectively [1] Low-Priced Stocks Ranking - The table lists various low-priced stocks along with their latest closing prices, daily price changes, turnover rates, price-to-book ratios, and industries [1] - Notable stocks include *ST Yuan Cheng at 0.58 yuan, *ST Su Wu at 1.02 yuan, and *ST Jin Ke at 1.48 yuan, with varying daily performance and industry classifications [1]

Core Insights - Small-cap stocks exhibit higher volatility and activity compared to large-cap stocks, making them more likely to become market leaders [1] Market Overview - As of November 18, there are 878 stocks with a circulating market value below 3 billion yuan, and 329 stocks with a circulating market value below 2 billion yuan [1] - A total of 1,609 stocks have a total market value below 5 billion yuan, with 470 stocks below 3 billion yuan [1] Smallest Stocks by Circulating Market Value - The three stocks with the smallest circulating market values are: - *ST元成: 189 million yuan - 坤泰股份: 677 million yuan - *ST苏吴: 690 million yuan [1] Smallest Stocks by Total Market Value - The three stocks with the smallest total market values are: - *ST元成: 189 million yuan - *ST苏吴: 690 million yuan - *ST长药: 774 million yuan [1] Selected Stocks with Low Circulating Market Value - A list of stocks with circulating market values below 2 billion yuan includes: - *ST元成: 189 million yuan, PE ratio: N/A, Industry: Construction Decoration - 坤泰股份: 677 million yuan, PE ratio: 49.21, Industry: Automotive - *ST苏吴: 690 million yuan, PE ratio: N/A, Industry: Pharmaceutical [1] - Additional stocks include 康力源 (716 million yuan, PE: 37.07, Light Industry), 科瑞思 (750 million yuan, PE: 183.29, Communication), and 万得凯 (767 million yuan, PE: 27.08, Machinery) [1] Additional Stocks with Low Total Market Value - Selected stocks with total market values below 2 billion yuan include: - *ST元成: 189 million yuan, Industry: Construction Decoration - *ST苏吴: 690 million yuan, Industry: Pharmaceutical - *ST长药: 774 million yuan, Industry: Pharmaceutical [1]

Core Viewpoint - The average stock price of A-shares is 13.89 yuan, with 19 stocks priced below 2 yuan, the lowest being *ST Yuan Cheng at 0.58 yuan [1] Stock Price Distribution - As of November 17, the Shanghai Composite Index closed at 3972.03 points, with a relatively small proportion of high-priced and low-priced stocks in the A-share market [1] - Among the low-priced stocks, 19 are priced below 2 yuan, with *ST Yuan Cheng being the lowest at 0.58 yuan, followed by *ST Su Wu at 0.98 yuan and *ST Jin Ke at 1.48 yuan [1] Characteristics of Low-Priced Stocks - Of the stocks priced below 2 yuan, 8 are ST stocks, accounting for 42.11% of this group [1] - In terms of market performance, 3 of the low-priced stocks increased in price, with *ST Su Wu, Liao Port Co., and Greenland Holdings rising by 1.03%, 0.57%, and 0.53% respectively [1] - Conversely, 10 stocks declined, with *ST Jin Ke, Rongsheng Development, and ST Yigou experiencing declines of 3.90%, 3.59%, and 3.30% respectively [1] Low-Priced Stock Rankings - The table lists various low-priced stocks, including their latest closing prices, daily price changes, turnover rates, price-to-book ratios, and industries [1]

Core Insights - Small-cap stocks exhibit higher volatility and activity compared to large-cap stocks, making them more likely to become market leaders [1] Market Overview - As of November 14, there are 863 stocks with a circulating market value below 3 billion yuan, and 325 stocks with a circulating market value below 2 billion yuan [1] - A total of 1,590 stocks have a total market value below 5 billion yuan, with 472 stocks below 3 billion yuan [1] Smallest Stocks by Circulating Market Value - The three stocks with the smallest circulating market values are: - *ST元成: 189 million yuan - *ST苏吴: 690 million yuan - 坤泰股份: 691 million yuan [1] Smallest Stocks by Total Market Value - The three stocks with the smallest total market values are: - *ST元成: 189 million yuan - *ST苏吴: 690 million yuan - *ST长药: 802 million yuan [1] Selected Stocks with Low Market Values - A list of stocks with circulating market values below 1 billion yuan includes: - *ST元成: 189 million yuan, PE ratio: N/A, Industry: Construction Decoration - *ST苏吴: 690 million yuan, PE ratio: N/A, Industry: Pharmaceutical Biology - 坤泰股份: 691 million yuan, PE ratio: 50.28, Industry: Automotive - 康力源: 715 million yuan, PE ratio: 37.01, Industry: Light Industry Manufacturing - 科瑞思: 748 million yuan, PE ratio: 182.81, Industry: Communication [1][2]

Core Viewpoint - The average stock price of A-shares is 13.92 yuan, with 20 stocks priced below 2 yuan, the lowest being *ST Yuan Cheng at 0.58 yuan [1] Stock Price Distribution - As of November 14, the Shanghai Composite Index closed at 3990.49 points, with a relatively small proportion of high-priced and low-priced stocks in the A-share market [1] - Among the low-priced stocks, 8 are ST stocks, accounting for 40% of those priced below 2 yuan [1] Market Performance - Out of the low-priced stocks, 18 saw an increase today, with notable gains from Rongsheng Development (10.17%), Yongtai Energy (9.82%), and *ST Jinke (4.76%) [1] Low-Priced Stock Rankings - The table lists various low-priced stocks, including their latest closing prices, daily price changes, turnover rates, price-to-book ratios, and industries [1] - For example, *ST Yuan Cheng has a closing price of 0.58 yuan, while *ST Suwu and *ST Jinke are at 0.97 yuan and 1.54 yuan respectively [1]